Circa Financial Statements From 2010 to 2024

CIRCA Stock  NOK 0.64  0.04  6.67%   
Circa Group financial statements provide useful quarterly and yearly information to potential Circa Group AS investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Circa Group financial statements helps investors assess Circa Group's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Circa Group's valuation are summarized below:
Circa Group AS does not presently have any fundamental signals for analysis.
Check Circa Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Circa Group's main balance sheet or income statement drivers, such as , as well as many indicators such as . Circa financial statements analysis is a perfect complement when working with Circa Group Valuation or Volatility modules.
  
This module can also supplement various Circa Group Technical models . Check out the analysis of Circa Group Correlation against competitors.

Circa Group AS Company Current Valuation Analysis

Circa Group's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Circa Group Current Valuation

    
  348.69 M  
Most of Circa Group's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Circa Group AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Circa Group AS has a Current Valuation of 348.69 M. This is 97.57% lower than that of the Healthcare sector and 92.49% lower than that of the Biotechnology industry. The current valuation for all Norway stocks is 97.9% higher than that of the company.

Circa Group AS Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Circa Group's current stock value. Our valuation model uses many indicators to compare Circa Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Circa Group competition to find correlations between indicators driving Circa Group's intrinsic value. More Info.
Circa Group AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Circa Group by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Circa Group's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Circa Group Financial Statements

Circa Group investors utilize fundamental indicators, such as revenue or net income, to predict how Circa Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Circa Group AS, a biotech company, engages in producing bio-based chemicals in Australia, France, the United Kingdom, Belgium, and Norway. The company was founded in 2006 and is headquartered in Oslo, Norway. CIRCA GROUP is traded on Oslo Stock Exchange in Norway.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Circa Stock

Circa Group financial ratios help investors to determine whether Circa Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Circa with respect to the benefits of owning Circa Group security.